BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 7092168)

  • 1. Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins.
    Lu-Steffes M; Iammartino AJ; Schmid FR; Castor CW; Davis L; Entwistle R; Anderson B
    Ann Clin Lab Sci; 1982; 12(3):178-85. PubMed ID: 7092168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease.
    Carsons S; Mosesson MW; Diamond HS
    Arthritis Rheum; 1981 Oct; 24(10):1261-7. PubMed ID: 6975631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the incorporation of fibronectin into synovial fluid cryoprotein.
    Carsons S; Lavietes BB; Diamond HS
    J Lab Clin Med; 1983 Nov; 102(5):722-31. PubMed ID: 6605399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin in plasma and synovial fluid of patients with rheumatic diseases.
    Duţu A; Vlaicu-Rus V; Boloşiu HD; Parasca I; Cristea A
    Med Interne; 1986; 24(1):61-8. PubMed ID: 3518030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occurrence of cryoproteins in synovial fluid; the association of a complement-fixing activity in rheumatoid synovial fluid with cold-precipitable protein.
    Marcus RL; Townes AS
    J Clin Invest; 1971 Feb; 50(2):282-93. PubMed ID: 4992991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
    Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
    Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma and synovial fibronectin. Results of personal research].
    Lecocq J; North ML; Grange D; Hauptmann G; Kuntz JL; Meyer R; Asch L
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):393-8. PubMed ID: 6494778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of complement components C3 and factor B in synovial fluids.
    Hunder GG; McDuffie FC; Mullen BJ
    J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical significance of synovial fluid examination].
    Yu MX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Aug; 11(4):274-7. PubMed ID: 2532973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlations between inflammatory activity, immunoglobulins and complement components in the synovial fluid of patients with rheumatoid arthritis and arthrosis].
    Stojan B; Hasler F
    Schweiz Med Wochenschr; 1978 Jul; 108(30):1165-8. PubMed ID: 675210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
    Stojan B
    Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of synovial fibronectin by laser nephelometry. Its diagnostic value in rheumatology].
    North ML; Lecocq J; Roth-Fritsch M; Piffaut MC; Asch L
    Ann Biol Clin (Paris); 1985; 43(6):861-6. PubMed ID: 3879577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood and synovial levels of C 3-activator (beta-2-glycoprotein II) in rheumatoid arthritis].
    Ambanelli U; Troise W; Riccardi L
    Reumatismo; 1975; 27(1):37-44. PubMed ID: 1233648
    [No Abstract]   [Full Text] [Related]  

  • 17. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3 cleavage product in synovial fluids detected by immunofixation.
    Partsch G; Bauer K; Bröll H; Petera P; Dunky A; Merétey K
    Z Rheumatol; 1991; 50(2):82-5. PubMed ID: 1872046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
    Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
    Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].
    Stojan B; Hasler F
    Wien Klin Wochenschr; 1977 Nov; 89(21):713-6. PubMed ID: 919557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.